Medpace CEO Troendle sells $6,749,952 of shares
President & CEO August J. Troendle sold 10,880 shares on September 17, 2026 at a weighted average price of $620.40, for a reported total sale amount of $6,749,952.
President & CEO August J. Troendle sold 10,880 shares on September 17, 2026 at a weighted average price of $620.40, for a reported total sale amount of $6,749,952.